IMP
Process View
positive regulation of hemostasis
Any process that activates or increases the frequency, rate or extent of hemostasis.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of hemostasis"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 1.000 | ||
| PLAU | plasminogen activator, urokinase | 0.971 | Human | |
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.832 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.676 | ||
| PLAT | plasminogen activator, tissue | 0.569 | Human | |
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.466 | ||
| ALB | albumin | 0.433 | ||
| MYD88 | myeloid differentiation primary response gene (88) | 0.417 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.301 | ||
| PLG | plasminogen | 0.279 | ||
| LY96 | lymphocyte antigen 96 | 0.245 | ||
| FGB | fibrinogen beta chain | 0.189 | ||
| TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.179 | ||
| FGA | fibrinogen alpha chain | 0.175 | ||
| SERPINC1 | serpin peptidase inhibitor, clade C (antithrombin), member 1 | 0.160 | ||
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.156 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.136 | ||
| APOH | apolipoprotein H (beta-2-glycoprotein I) | 0.130 | ||
| TICAM2 | toll-like receptor adaptor molecule 2 | 0.125 | ||
| ORM1 | orosomucoid 1 | 0.115 | ||
| MAFG | v-maf musculoaponeurotic fibrosarcoma oncogene homolog G (avian) | 0.101 | ||
| CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.098 | ||
| MASP2 | mannan-binding lectin serine peptidase 2 | 0.077 | ||
| LPA | lipoprotein, Lp(a) | 0.074 | Human | |
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.070 | ||
| KNG1 | kininogen 1 | 0.066 | ||
| C1R | complement component 1, r subcomponent | 0.047 | ||
| C1S | complement component 1, s subcomponent | 0.046 | ||
| TIRAP | toll-interleukin 1 receptor (TIR) domain containing adaptor protein | 0.045 | ||
| C8A | complement component 8, alpha polypeptide | 0.044 | ||
| CD320 | CD320 molecule | 0.037 | ||
| F3 | coagulation factor III (thromboplastin, tissue factor) | 0.037 | ||
| ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 0.034 | ||
| C8B | complement component 8, beta polypeptide | 0.034 | ||
| VTN | vitronectin | 0.032 | ||
| F13A1 | coagulation factor XIII, A1 polypeptide | 0.026 | ||
| INSR | insulin receptor | 0.025 | ||
| PRODH2 | proline dehydrogenase (oxidase) 2 | 0.023 | ||
| F10 | coagulation factor X | 0.022 | Human | |
| ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.021 | ||
| F11 | coagulation factor XI | 0.021 | ||
| BACH1 | BTB and CNC homology 1, basic leucine zipper transcription factor 1 | 0.020 | ||
| AHSG | alpha-2-HS-glycoprotein | 0.020 | ||
| SERPINA5 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 | 0.018 | ||
| PROCR | protein C receptor, endothelial | 0.018 | ||
| F2 | coagulation factor II (thrombin) | 0.017 | ||
| PCOLCE | procollagen C-endopeptidase enhancer | 0.016 | ||
| BAD | BCL2-associated agonist of cell death | 0.016 | ||
| RANBP9 | RAN binding protein 9 | 0.016 | ||
| THBS1 | thrombospondin 1 | 0.016 | ||
| SDPR | serum deprivation response | 0.015 | ||
| HPX | hemopexin | 0.015 | ||
| ASGR2 | asialoglycoprotein receptor 2 | 0.015 | ||
| ITIH2 | inter-alpha (globulin) inhibitor H2 | 0.014 | ||
| APOA2 | apolipoprotein A-II | 0.014 | ||
| CLEC4G | C-type lectin domain family 4, member G | 0.013 | ||
| EIF2AK3 | eukaryotic translation initiation factor 2-alpha kinase 3 | 0.013 | ||
| INPP5A | inositol polyphosphate-5-phosphatase, 40kDa | 0.013 | ||
| CYR61 | cysteine-rich, angiogenic inducer, 61 | 0.013 | ||
| CALD1 | caldesmon 1 | 0.013 | ||
| EMP1 | epithelial membrane protein 1 | 0.013 | ||
| SPP2 | secreted phosphoprotein 2, 24kDa | 0.013 | ||
| CYP1A2 | cytochrome P450, family 1, subfamily A, polypeptide 2 | 0.013 | ||
| IRS2 | insulin receptor substrate 2 | 0.012 | ||
| OSMR | oncostatin M receptor | 0.012 | ||
| TFPI | tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) | 0.012 | ||
| SFRP4 | secreted frizzled-related protein 4 | 0.012 | ||
| SPHK1 | sphingosine kinase 1 | 0.012 | ||
| ENPP5 | ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative) | 0.012 | ||
| ITIH3 | inter-alpha (globulin) inhibitor H3 | 0.012 | ||
| FTCD | formiminotransferase cyclodeaminase | 0.012 | ||
| HMGCS2 | 3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) | 0.011 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.011 | ||
| AGXT | alanine-glyoxylate aminotransferase | 0.011 | ||
| F9 | coagulation factor IX | 0.011 | Human | |
| CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 | 0.010 | ||
| SERPINA10 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10 | 0.010 | ||
| NNMT | nicotinamide N-methyltransferase | 0.010 |